Home » Tenders » Americas » USA » Human Donor Blood for Bioassay Development Tender, USA - 105261066

Human Donor Blood for Bioassay Development Tender, USA - 105261066

HEALTH AND HUMAN SERVICES, DEPARTMENT OF | FOOD AND DRUG ADMINISTRATION has floated a tender for Human Donor Blood for Bioassay Development. The project location is USA and the tender is closing on 13 Aug 2024. The tender notice number is 75F40124Q00461, while the TOT Ref Number is 105261066. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Human Donor Blood for Bioassay Development

Deadline : 13 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 105261066

Document Ref. No. : 75F40124Q00461

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

Solicitation Number:75F40124Q00412This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 and FAR 13 as supplemented and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05, effective 05/22/2024.THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATESOLICITATION WILL NOT BE ISSUED.The solicitation number for this acquisition is 75F40124Q00412 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation is 621991. This will be awarded as Firm-Fixed Price as competed as Full and Open. Prospective Offerors are responsible for downloading the solicitation and any amendments from SAM.GOV. The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing the Best Value and discussions are not necessary.The U.S. Food and Drug Administration (FDA) requires a Human Donor Blood for BioAssay Development Delivery.A. OBJECTIVES/PURPOSEFor the development of bioassays using peripheral blood mononuclear cells (PBMC) and/or isolated immune cells, we require a reliable and steady source of blood products from human donors.

See attached RFQ CB Synopsis Solicitation .
Active Contract Opportunity
Notice ID : 75F40124Q00461
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : FOOD AND DRUG ADMINISTRATION
Office: FDA OFFICE OF ACQ GRANT SVCS
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 03, 2024 11:24 pm EDT
Original Date Offers Due: Aug 13, 2024 10:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Aug 28, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 621991 - Blood and Organ Banks

Place of Performance: Silver Spring, MD 20903 USA